Comparison of C4d detection on erythrocytes and PTC-C4d to histological signs of antibody-mediated rejection in kidney transplantation

American Journal of Transplantation

Volumn 12, Issue 6, 2012, Pages 1564-1575

  Haidar, F ^a,b,c   Kisserli, A ^a,b   Tabary, T ^a,b   McGregor, B ^d   Noel, L H ^e   Reveil B ^a   Toupance, O ^c   Rieu, P ^c   Thervet, E ^e   Legendre, C ^e   Morelon, E ^d   Issa, N ^f   Cohen, J H M ^a,b  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c HÔPITAL MAISON BLANCHE   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Complement; erythrocytes; humoral rejection; kidney transplantation

Indexed keywords

COMPLEMENT COMPONENT C4D;

ADULT; AGED; ANTIBODY MEDIATED REJECTION; ARTICLE; BIOPSY TECHNIQUE; BLOOD ANALYSIS; CAPILLARITIS; CROSS-SECTIONAL STUDY; ERYTHROCYTE; FEMALE; FOLLOW UP; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PERITUBULAR CAPILLARITIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; COMPLEMENT C4B; ERYTHROCYTES; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS;

EID: 84861824994     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04003.x     Document Type: Article

References (34)

1. Perico N, Cattaneo D, Sayegh MH, Remuzzi G,. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827.
2. Feucht HE, Mihatsch MJ,. Diagnostic value of C4d in renal biopsies. Curr Opin Nephrol Hypertens 2005; 14: 592-598.
3. Torrealba JR, Samaniego M, Pascual J, et al,. C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts. Transplantation 2008; 86: 1849-1856.
4. Troxell ML, Higgins JP, Kambham N,. Evaluation of C4d staining in liver and small intestine allografts. Arch Pathol Lab Med 2006; 130: 1489-1496.
5. Uber WE, Self SE, Van Bakel AB, Pereira NL,. Acute antibody-mediated rejection following heart transplantation. Am J Transplant 2007; 7: 2064-2074.
6. Westall GP, Snell GI, McLean C, Kotsimbos T, Williams T, Magro C,. C3d and C4d deposition early after lung transplantation. J Heart Lung Transplant 2008; 27: 722-728.
7. Sis B, Mengel M, Haas M, et al,. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464-471.
8. Einecke G, Sis B, Reeve J, et al,. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
9. Hidalgo LG, Campbell PM, Sis B, et al,. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9: 2532-2541.
10. Sis B, Halloran PF,. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010; 15: 42-48.
11. Bechtel U, Scheuer R, Landgraf R, Konig A, Feucht HE,. Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients. Transplantation 1994; 58: 905-911.
12. Honger G, Mayr M, Dickenmann M, Mihatsch MJ, Schaub S,. Urinary C4d does not correlate with C4d-staining in peritubular capillaries but reflects nonspecific glomerular injury. Transplantation 2008; 85: 542-546.
13. Lepin EJ, Zhang Q, Zhang X, et al,. Phosphorylated S6 ribosomal protein: A novel biomarker of antibody-mediated rejection in heart allografts. Am J Transplant 2006; 6: 1560-1571.
14. Yannaraki M, Rebibou JM, Ducloux D, et al,. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. Transpl Int 2006; 19: 759-768.
15. Nordhagen R, Heier Larsen AM, Beckers D,. Chido, Rodgers and C4. In vivo and in vitro coating of red blood cells, grouping and antibody detection. Vox Sang 1979; 37: 170-178.
16. Tilley CA, Romans DG, Crookston MC,. Localisation of Chido and Rodgers determinants to the C4d fragment of human C4. Nature 1978; 276: 713-715.
17. Liu CC, Manzi S, Kao AH, Navratil JS, Ruffing MJ, Ahearn JM,. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. Arthritis Rheum 2005; 52: 3087-3099.
18. Manzi S, Navratil JS, Ruffing MJ, et al,. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3596-3604.
19. Singh V, Mahoney JA, Petri M,. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. J Rheumatol 2008; 35: 1989-1993.
20. Solez K, Colvin RB, Racusen LC, et al,. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518-526.
21. Böhmig GA, Exner M, Habicht A, et al,. Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13: 1091-1099.
22. Kawamura N, Tomita M, Hasegawa M, et al,. Complement C4d deposition in transplanted kidneys: preliminary report on long-term graft survival. Clin Transpl 2005; 13: 27-31.
23. Mauiyyedi S, Crespo M, Collins AB, et al,. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779-787.
24. Racusen LC, Colvin RB, Solez K, et al,. Antibody-mediated rejection criteria: An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714.
25. Troxell ML, Weintraub LA, Higgins JP, Kambham N,. Comparison of C4d immunostaining methods in renal allograft biopsies. Clin J Am Soc Nephrol 2006; 1: 583-591.
26. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF,. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312-2323.
27. Cosio FG, Lager DJ, Lorenz EC, Amer H, Gloor JM, Stegall MD,. Significance and implications of capillaritis during acute rejection of kidney allografts. Transplantation 2010; 89: 1088-1094.
28. Bartel G, Wahrmann M, Exner M, et al,. In vitro detection of C4d-fixing HLA alloantibodies: Associations with capillary C4d deposition in kidney allografts. Am J Transplant 2008; 8: 41-49.
29. Golocheikine A, Nath DS, Basha HI, et al,. Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients. J Heart Lung Transplant 2010; 29: 410-416.
30. Lee KC, Chang CY, Chuang YC, et al,. Measurement of human erythrocyte C4d to erythrocyte complement receptor 1 ratio in cardiac transplant recipients with acute symptomatic allograft failure. Transplant Proc 2008; 40: 2638-2642.
31. Ollert MW, Kadlec JV, David K, Petrella EC, Bredehorst R, Vogel CW,. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps. J Immunol 1994; 153: 2213-2221.
32. Feucht HE, Opelz G,. The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int 1996; 50: 1464-1475.
33. Mauiyyedi S, Colvin RB,. Humoral rejection in kidney transplantation: New concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 2002; 11: 609-618.
34. Scornik JC, Meier-Kriesche HU,. Blood transfusions in organ transplant patients: Mechanisms of sensitization and implications for prevention. Am J Transplant 2011; 11: 1785-1791.